These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37841365)

  • 21. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
    J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
    Tan TS; Toyoda M; Ode H; Barabona G; Hamana H; Kitamatsu M; Kishi H; Motozono C; Iwatani Y; Ueno T
    J Virol; 2022 Oct; 96(20):e0116222. PubMed ID: 36214577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
    Noor R; Shareen S; Billah M
    Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
    Chand GB; Banerjee A; Azad GK
    Gene Rep; 2020 Dec; 21():100891. PubMed ID: 33015411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable number tandem repeats of a 9-base insertion in the N-terminal domain of severe acute respiratory syndrome coronavirus 2 spike gene.
    Akaishi T; Fujiwara K; Ishii T
    Front Microbiol; 2022; 13():1089399. PubMed ID: 36687631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Vale FF; Vítor JMB; Marques AT; Azevedo-Pereira JM; Anes E; Goncalves J
    Virus Res; 2021 Oct; 304():198526. PubMed ID: 34339772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    Lavie M; Dubuisson J; Belouzard S
    J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.
    Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Belém MO; Pinto YO; Moreira HHT; Magalhaes ICL; Castelo-Branco DSCM; Montenegro RC; de Andrade CR
    Int J Biol Macromol; 2022 May; 208():105-125. PubMed ID: 35300999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research progress in spike mutations of SARS-CoV-2 variants and vaccine development.
    He X; He C; Hong W; Yang J; Wei X
    Med Res Rev; 2023 Jul; 43(4):932-971. PubMed ID: 36929527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservation analysis of SARS-CoV-2 spike suggests complicated viral adaptation history from bat to human.
    Lei KC; Zhang XD
    Evol Med Public Health; 2020; 2020(1):290-303. PubMed ID: 33372198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semicovariance Coefficient Analysis of Spike Proteins from SARS-CoV-2 and Other Coronaviruses for Viral Evolution and Characteristics Associated with Fatality.
    Huang JS; Huang JM; Zhang W
    Entropy (Basel); 2021 Apr; 23(5):. PubMed ID: 33922613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.